Peritoneal Dialysis Market by Type, Product, End Use

List of Tables

[198 Pages Report] The Peritoneal Dialysis Market size was estimated at USD 5.00 billion in 2023 and expected to reach USD 5.33 billion in 2024, at a CAGR 7.01% to reach USD 8.03 billion by 2030.

Peritoneal dialysis is a medical technique used to draw excess fluid and waste products from the body when the kidneys are not functioning properly. This procedure employs the patient's peritoneum, a membrane lining the abdominal cavity, as a filter. During peritoneal dialysis, a special fluid is introduced into the abdominal cavity through a catheter, where it absorbs waste materials and excess fluids. The fluid is then drained and discarded, typically several times a day. An increase in conditions such as diabetes and hypertension, which are leading causes of CKD, significantly contributes to the demand for peritoneal dialysis. Additionally, there's a growing inclination towards getting dialysis treatment at home due to its convenience and cost-effectiveness, boosting the adoption of peritoneal dialysis. However, the risk of peritonitis, an infection of the peritoneum, which can lead to severe complications, poses significant challenges to peritoneal dialysis. Furthermore, innovations in dialysis solutions and devices aimed at improving patient comfort and treatment efficacy provide opportunities to the manufacturers. Leveraging telehealth for remote monitoring of peritoneal dialysis patients can improve patient outcomes and expand market reach.

KEY MARKET STATISTICS
Base Year [2023]	USD 5.00 billion
Estimated Year [2024]	USD 5.33 billion
Forecast Year [2030]	USD 8.03 billion
CAGR (%)	7.01%

Type: Increasing significance for continuous ambulatory peritoneal dialysis as it offers more flexibility and control over the dialysis process

Automated peritoneal dialysis primarily uses a machine called a cycler to perform exchanges at night while the patient sleeps. This type of dialysis is best suited for patients seeking flexibility in their daily schedule or those who are not capable of conducting manual exchanges throughout the day. Continuous ambulatory peritoneal dialysis, in contrast, is a manual dialysis method that does not require a machine. Exchanges are carried out four to five times a day, manually, by the patient or a caregiver. This modality is often preferred by patients who want to maintain a certain degree of physical activity or those who may not have access to reliable electricity needed for APD.

End Use: Patients requiring closer medical supervision often prefer dialysis centers

Dialysis Centers are facilities specifically designed to offer dialysis treatment, including both hemodialysis and peritoneal dialysis. For PD, these centers frequently serve as the initial point for education, training, and sometimes treatment. Patients opting for PD can receive direct supervision and assistance from healthcare professionals in these settings. Home care settings for peritoneal dialysis signify the patient's residence is equipped with the necessary PD equipment and supplies. Home PD allows patients to perform their dialysis treatment according to their schedule without the need to frequent a dialysis center or hospital. Hospitals offering peritoneal dialysis cater to patients who are either in the initiation phase of PD, have multiple health conditions, or require acute care management. Hospitals are equipped with a wide range of medical services and facilities for the comprehensive management of patient's health, including any complications from PD.

Regional Insights

The American region is at the forefront in terms of peritoneal dialysis adoption due to its advanced healthcare system, strong patient support programs, and significant investment in research and patents. Medicare, under the ESRD (End-Stage Renal Disease) benefit, provides coverage for dialysis, encouraging PD due to its cost-effectiveness. Ongoing innovations have focused on improving PD solutions and equipment aimed at enhancing patient safety and convenience. The EU has shown steady growth in PD adoption, with varying rates across countries. Initiatives such as the European Renal Care Providers Association (ERCPA) aim to standardize PD care. Investment in research focuses on improving PD technologies and reducing peritonitis. In wealthier Middle Eastern countries, there is significant investment in healthcare, with growing interest in peritoneal dialysis. In contrast, African countries face challenges related to healthcare infrastructure and affordability. Initiatives in these regions aim to improve access to PD through partnerships and funding from international organizations. With a large ESRD patient population, the APAC is witnessing rapid growth in PD adoption, supported by government reforms in healthcare and investment in dialysis centers. Innovations and localized production of peritoneal dialysis supplies have made the treatment more accessible. Moreover, the APAC benefits from strong research initiatives and technological advancements in peritoneal dialysis.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Peritoneal Dialysis Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Peritoneal Dialysis Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Peritoneal Dialysis Market, highlighting leading vendors and their innovative profiles. These include Advin Health Care, Angiplast Pvt. Ltd., Asahi Kasei Corporation, AWAK Technologies, B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Cook Group Incorporated, DaVita Inc., Diaverum AB, Fresenius Medical Care AG & Co. KGaA, JDmeditech, JMS Co., Ltd., Medionics International Inc., Medtronic PLC, Mitra Industries, Nipro Corporation, Opterion Health AG, Renax Biomedical Technology Co., Ltd., Terumo Corporation, and Toray Industries, Inc..

Market Segmentation & Coverage

This research report categorizes the Peritoneal Dialysis Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Automated Peritoneal Dialysis
- Continuous Ambulatory Peritoneal Dialysis

Product
- Dialysis Solution
- Peritoneal Dialysis Catheters

End Use
- Dialysis Centers
- Home Care Settings
- Hospitals

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Peritoneal Dialysis Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Peritoneal Dialysis Market?

3. What are the technology trends and regulatory frameworks in the Peritoneal Dialysis Market?

4. What is the market share of the leading vendors in the Peritoneal Dialysis Market?

5. Which modes and strategic moves are suitable for entering the Peritoneal Dialysis Market?

Product Code: MRR-030EE485159D

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing number of end-stage renal failure patients
  - 5.1.1.2. Rising healthcare expenditure and rising awareness of peritoneal dialysis
  - 5.1.1.3. Growing prevalence of diabetes and hypertension
- 5.1.2. Restraints
  - 5.1.2.1. Risks associated with infection of the peritoneum and other complexities
- 5.1.3. Opportunities
  - 5.1.3.1. Leveraging telehealth for remote monitoring of peritoneal dialysis patients
  - 5.1.3.2. Innovations in dialysis solutions and devices, aimed at improving patient comfort and treatment efficacy
- 5.1.4. Challenges
  - 5.1.4.1. Concerns regarding technical complexity and reimbursement policies
5.2. Market Segmentation Analysis
- 5.2.1. Type: Increasing significance for continuous ambulatory peritoneal dialysis as it offers more flexibility and control over the dialysis process
- 5.2.2. End Use: Patients requiring closer medical supervision often prefer dialysis centers
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Peritoneal Dialysis Market, by Type

6.1. Introduction
6.2. Automated Peritoneal Dialysis
6.3. Continuous Ambulatory Peritoneal Dialysis

7. Peritoneal Dialysis Market, by Product

7.1. Introduction
7.2. Dialysis Solution
7.3. Peritoneal Dialysis Catheters

8. Peritoneal Dialysis Market, by End Use

8.1. Introduction
8.2. Dialysis Centers
8.3. Home Care Settings
8.4. Hospitals

9. Americas Peritoneal Dialysis Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Peritoneal Dialysis Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Peritoneal Dialysis Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
- 12.3.1. Mitra Industries Introduces Advanced Triple-Chambered PD Bag for Peritoneal Dialysis
- 12.3.2. Pioneering Advancements in Peritoneal Dialysis: Opterion Health Secures Significant Funding for Clinical Trials
- 12.3.3. AWAK Technologies Raises Series B Funding for Innovations in Peritoneal Dialysis
12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

13.1. Key Company Profiles
13.2. Key Product Portfolio